IntrinsicIntrinsic
← Scroll for more →

Radiopharm Theranostics Ltd (RADX)

Business Summary

Radiopharm Theranostics Limited is a clinical-stage radiotherapeutics company incorporated in Australia in February 2021, focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company operates in the radiopharmaceutical industry, which involves the use of radioactive materials for medical imaging and therapy. The industry is characterized by significant research and development activities, regulatory oversight, and the need for substantial capital investment. Radiopharm's position within this landscape is that of a development-stage entity with no approved products or product revenue, relying on equity financings and strategic collaborations to fund its operations.

The company faces competition from entities that may develop drug candidates for its target disease indications, including companies developing novel treatments and technology platforms based on modalities and technology similar to its own. Radiopharm's competitive position is not quantified in terms of market share, but its strategy relies on a portfolio of intellectual property assets, including in-licensed and acquired drug candidates targeting various cancer indications. The company's ability to compete depends on the successful development, regulatory approval, and commercialization of its drug candidates, as well as its ability to protect its intellectual property and secure necessary funding.

Radiopharm's core business model is the development of radiopharmaceutical drug candidates for diagnostic and therapeutic uses. The company currently has no source of product revenue and does not expect to receive revenue from its drug candidates for a number of years, if ever. Its revenue generation, if successful, would come from the licensing or commercialization of its drug candidates, either alone or with future partners. The company has historically financed its operations through equity financings, including an At the Market facility with Leerink Partners LLC, and may seek additional funding through public or private financings, licensing of assets, or arrangements with corporate partners.

The company's product pipeline includes several drug candidates at various stages of development. These include a huPSA antibody for prostate cancer imaging, an AVb6 integrin-targeting product (68Ga-Trivehexin) for diagnostic applications, a NanoMab platform with candidates targeting HER2, TROP2, and PD-L1, a Pivalate therapeutic candidate, and other intellectual property assets. Each candidate is in preclinical or clinical development, with milestones such as IND submissions, clinical trial initiations, and regulatory approvals tied to contingent consideration payments. The company does not report segment revenue as it has no product sales.

During the fiscal year, Radiopharm engaged in several significant operational activities. The company raised capital through a rights issue and issued placement shares to Lantheus, among other equity transactions. It also entered into or advanced agreements related to its intellectual property, including the Radiopharm Ventures LLC agreement with MD Anderson, which includes milestone-based contingent consideration. The company also has an ATM facility with Leerink Partners LLC for future capital raises. These activities are part of its strategy to fund research and development and progress its clinical programs.

For the fiscal year ended June 30, 2026, Radiopharm reported a total comprehensive loss of A$56.33 million and negative cash flows from operating activities of approximately A$52.78 million. As of June 30, 2026, the company had accumulated losses of A$199.66 million. The company has a history of significant recurring operating losses and negative cash flows since inception, and it expects to continue incurring losses for the foreseeable future as it advances its drug candidates through clinical development.

Business Outlook & Financial Sufficiency

Radiopharm expects to continue to incur significant losses in the development of its clinical trials and drug candidates, with costs expected to increase as more patients are recruited. The company anticipates that its expenses will increase substantially for the foreseeable future as it continues research and preclinical and clinical development, expands the scope of its proposed clinical studies, and potentially develops marketing and sales capabilities. Based on current budget forecast assumptions, management expects to be able to meet obligations and continue research and development programs for at least the next 12 months, but this is dependent on the ability to access additional funding.

A key growth vector is the advancement of its drug candidates through clinical development. The company's pipeline includes multiple candidates with defined milestones, such as the huPSA antibody for prostate cancer, which has milestones including first patient in pivotal studies and regulatory submissions to the FDA, EMA, and PMDA. The AVb6 integrin product, 68Ga-Trivehexin, has milestones for diagnostic clinical trials and marketing approvals in Japan, China, Hong Kong, or the United States. The NanoMab platform includes candidates targeting HER2, TROP2, and PD-L1, with milestones for IND submissions and clinical trial initiations. The Pivalate therapeutic candidate has milestones for clinical trial commencements and regulatory approvals in the US, EU, or UK.

Another growth vector is the company's strategic collaborations and licensing agreements. The Radiopharm Ventures LLC agreement with MD Anderson includes contingent consideration tied to development and regulatory milestones for licensed products, including those targeting B7H3. The company also has agreements related to its Pivalate and NanoMab intellectual property, with milestone payments based on net sales and regulatory approvals. These partnerships are intended to provide funding and de-risk development, but the company currently has no agreements that could provide material, ongoing future revenue.

The company's margin and cost outlook is characterized by increasing research and development expenses as clinical trials expand. The company does not report gross or operating margins as it has no product revenue. Operating costs are expected to rise, and the company may employ cash management strategies, including delaying or reducing certain operating activities, to manage its cash position. The company's ability to achieve profitability is uncertain and depends on successful commercialization of its drug candidates.

Operationally, Radiopharm relies on third-party manufacturing and supply partners for its research and development, preclinical, and clinical development materials. The company has limited manufacturing experience and depends on contractors for these activities. It also relies on collaboration and strategic alliances with third parties. The company's ability to manage its growth and retain key management personnel and academic collaborations is critical to its operations.

Capital allocation is focused on funding research and development. The company has financed operations through equity financings, including an ATM facility with Leerink Partners LLC. It may seek additional funding through public or private financings, licensing of assets, or corporate partnerships. The company does not pay dividends and has not disclosed a share repurchase program. R&D spending is expected to increase, and the company may need to raise additional capital to fund its programs.

A significant headwind is the company's history of operating losses and negative cash flows, with a total comprehensive loss of A$56.33 million for fiscal 2026 and accumulated losses of A$199.66 million as of June 30, 2026. The company has no source of product revenue and may never become profitable. It will require additional financing to continue operations, and there is a material uncertainty regarding its ability to continue as a going concern, dependent on its ability to raise capital.

Regulatory and clinical development risks are major constraints. The company's drug candidates may not show sufficient safety and efficacy in clinical trials to obtain regulatory approvals. The company may face difficulties in enrolling patients in clinical trials, and patients could discontinue participation. Positive preclinical results are not necessarily predictive of clinical trial outcomes. The company also faces risks related to intellectual property protection and potential competition from other entities developing similar treatments.

Management Sentiments & Priorities

Management's message emphasizes the company's focus on developing radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The tone is cautious, acknowledging the company's history of operating losses and the uncertainty of future profitability. Management highlights the expectation to continue incurring significant losses as clinical trials expand, and the need for additional funding to achieve long-term goals. Strategic priorities include advancing the clinical development of drug candidates, securing funding through equity financings and partnerships, and managing cash resources to sustain operations for at least the next 12 months. Management believes the going concern basis is appropriate, despite material uncertainty, based on the ability to access additional funding and employ cash management strategies.

Financial Details

For the fiscal year ended June 30, 2026, Radiopharm reported a total comprehensive loss of A$56.33 million, compared to a loss of A$43.42 million in the prior fiscal year (as derived from the accumulated losses figure of A$199.66 million at June 30, 2026, and A$156.24 million at June 30, 2025, which is not explicitly stated but implied by the change). The company had negative cash flows from operating activities of approximately A$52.78 million in fiscal 2026. As of June 30, 2026, the company had accumulated losses of A$199.66 million. The company has no product revenue, and its net loss is driven by research and development expenses, which are expected to increase. The company's cash position is not explicitly stated in the provided text, but it has raised capital through equity financings, including a rights issue and placement shares to Lantheus. The company's financial statements are prepared in Australian dollars under IFRS.

Risk Factors

The most material risks to Radiopharm's business include its history of operating losses and negative cash flows, with a total comprehensive loss of A$56.33 million for fiscal 2026 and accumulated losses of A$199.66 million as of June 30, 2026. The company has no source of product revenue and may never become profitable, and it will require additional financing to continue operations. There is a material uncertainty regarding its ability to continue as a going concern, dependent on its ability to raise capital. The company's drug candidates may fail to show sufficient safety and efficacy in clinical trials, and it may face difficulties in enrolling patients. The company relies on third-party manufacturing and supply partners, and any interruption could limit or disrupt its development materials. Additionally, the company faces competition from entities developing similar treatments, and its success depends on protecting its intellectual property.

References

  1. [1] Item 3.D, Risk Factors
  2. [2] Item 3.D, Risk Factors
  3. [3] Item 3.D, Risk Factors
  4. [4] Item 3.D, Risk Factors
  5. [5] Item 3.D, Risk Factors
  6. [6] Item 3.D, Risk Factors
  7. [7] Item 3.D, Risk Factors
  8. [8] Item 3.D, Risk Factors
  9. [9] Item 3.D, Risk Factors
  10. [10] Item 3.D, Risk Factors
  11. [11] Item 3.D, Risk Factors
  12. [12] Item 3.D, Risk Factors
  13. [13] Item 3.D, Risk Factors
  14. [14] Item 3.D, Risk Factors
  15. [15] Item 3.D, Risk Factors
  16. [16] Item 3.D, Risk Factors
  17. [17] Item 3.D, Risk Factors
  18. [18] Item 3.D, Risk Factors
  19. [19] Item 3.D, Risk Factors
  20. [20] Item 3.D, Risk Factors
  21. [21] Item 3.D, Risk Factors
  22. [22] Item 3.D, Risk Factors
  23. [23] Item 3.D, Risk Factors
  24. [24] Item 3.D, Risk Factors
  25. [25] Item 3.D, Risk Factors
  26. [26] Item 3.D, Risk Factors
  27. [27] Item 3.D, Risk Factors
  28. [28] Item 3.D, Risk Factors
  29. [29] Item 3.D, Risk Factors
  30. [30] Item 3.D, Risk Factors
  31. [31] Item 3.D, Risk Factors
  32. [32] Item 3.D, Risk Factors
  33. [33] Item 3.D, Risk Factors
  34. [34] Item 3.D, Risk Factors
  35. [35] Item 3.D, Risk Factors
  36. [36] Item 3.D, Risk Factors
  37. [37] Item 3.D, Risk Factors
  38. [38] Item 3.D, Risk Factors
  39. [39] Item 3.D, Risk Factors
  40. [40] Item 3.D, Risk Factors
  41. [41] Item 3.D, Risk Factors
  42. [42] Item 3.D, Risk Factors
  43. [43] Item 3.D, Risk Factors
  44. [44] Item 3.D, Risk Factors
  45. [45] Item 3.D, Risk Factors
  46. [46] Item 3.D, Risk Factors
  47. [47] Item 3.D, Risk Factors
  48. [48] Item 3.D, Risk Factors
  49. [49] Item 3.D, Risk Factors
  50. [50] Item 3.D, Risk Factors
  51. [51] Item 3.D, Risk Factors
  52. [52] Item 3.D, Risk Factors
  53. [53] Item 3.D, Risk Factors
  54. [54] Item 3.D, Risk Factors
  55. [55] Item 3.D, Risk Factors
  56. [56] Item 3.D, Risk Factors
  57. [57] Item 3.D, Risk Factors
  58. [58] Item 3.D, Risk Factors
  59. [59] Item 3.D, Risk Factors
  60. [60] Item 3.D, Risk Factors
  61. [61] Item 3.D, Risk Factors
  62. [62] Item 3.D, Risk Factors
  63. [63] Item 3.D, Risk Factors
  64. [64] Item 3.D, Risk Factors
  65. [65] Item 3.D, Risk Factors
  66. [66] Item 3.D, Risk Factors
  67. [67] Item 3.D, Risk Factors
  68. [68] Item 3.D, Risk Factors
  69. [69] Item 3.D, Risk Factors
  70. [70] Item 3.D, Risk Factors
  71. [71] Item 3.D, Risk Factors
  72. [72] Item 3.D, Risk Factors
  73. [73] Item 3.D, Risk Factors
  74. [74] Item 3.D, Risk Factors
  75. [75] Item 3.D, Risk Factors
  76. [76] Item 3.D, Risk Factors
  77. [77] Item 3.D, Risk Factors
  78. [78] Item 3.D, Risk Factors
  79. [79] Item 3.D, Risk Factors
  80. [80] Item 3.D, Risk Factors
  81. [81] Item 3.D, Risk Factors
  82. [82] Item 3.D, Risk Factors
  83. [83] Item 3.D, Risk Factors
  84. [84] Item 3.D, Risk Factors
  85. [85] Item 3.D, Risk Factors
  86. [86] Item 3.D, Risk Factors
  87. [87] Item 3.D, Risk Factors
  88. [88] Item 3.D, Risk Factors
  89. [89] Item 3.D, Risk Factors
  90. [90] Item 3.D, Risk Factors
  91. [91] Item 3.D, Risk Factors
  92. [92] Item 3.D, Risk Factors
  93. [93] Item 3.D, Risk Factors
  94. [94] Item 3.D, Risk Factors
  95. [95] Item 3.D, Risk Factors
  96. [96] Item 3.D, Risk Factors
  97. [97] Item 3.D, Risk Factors
  98. [98] Item 3.D, Risk Factors
  99. [99] Item 3.D, Risk Factors
  100. [100] Item 3.D, Risk Factors
  101. [101] Item 3.D, Risk Factors
  102. [102] Item 3.D, Risk Factors
  103. [103] Item 3.D, Risk Factors
  104. [104] Item 3.D, Risk Factors
  105. [105] Item 3.D, Risk Factors
  106. [106] Item 3.D, Risk Factors
  107. [107] Item 3.D, Risk Factors
  108. [108] Item 3.D, Risk Factors
  109. [109] Item 3.D, Risk Factors
  110. [110] Item 3.D, Risk Factors
  111. [111] Item 3.D, Risk Factors
  112. [112] Item 3.D, Risk Factors
  113. [113] Item 3.D, Risk Factors
  114. [114] Item 3.D, Risk Factors
  115. [115] Item 3.D, Risk Factors
  116. [116] Item 3.D, Risk Factors
  117. [117] Item 3.D, Risk Factors
  118. [118] Item 3.D, Risk Factors
  119. [119] Item 3.D, Risk Factors
  120. [120] Item 3.D, Risk Factors
  121. [121] Item 3.D, Risk Factors
  122. [122] Item 3.D, Risk Factors
  123. [123] Item 3.D, Risk Factors
  124. [124] Item 3.D, Risk Factors
  125. [125] Item 3.D, Risk Factors
  126. [126] Item 3.D, Risk Factors
  127. [127] Item 3.D, Risk Factors
  128. [128] Item 3.D, Risk Factors
  129. [129] Item 3.D, Risk Factors
  130. [130] Item 3.D, Risk Factors
  131. [131] Item 3.D, Risk Factors
  132. [132] Item 3.D, Risk Factors
  133. [133] Item 3.D, Risk Factors
  134. [134] Item 3.D, Risk Factors
  135. [135] Item 3.D, Risk Factors
  136. [136] Item 3.D, Risk Factors
  137. [137] Item 3.D, Risk Factors
  138. [138] Item 3.D, Risk Factors
  139. [139] Item 3.D, Risk Factors
  140. [140] Item 3.D, Risk Factors
  141. [141] Item 3.D, Risk Factors
  142. [142] Item 3.D, Risk Factors
  143. [143] Item 3.D, Risk Factors
  144. [144] Item 3.D, Risk Factors
  145. [145] Item 3.D, Risk Factors
  146. [146] Item 3.D, Risk Factors
  147. [147] Item 3.D, Risk Factors
  148. [148] Item 3.D, Risk Factors
  149. [149] Item 3.D, Risk Factors
  150. [150] Item 3.D, Risk Factors
  151. [151] Item 3.D, Risk Factors
  152. [152] Item 3.D, Risk Factors
  153. [153] Item 3.D, Risk Factors
  154. [154] Item 3.D, Risk Factors
  155. [155] Item 3.D, Risk Factors
  156. [156] Item 3.D, Risk Factors
  157. [157] Item 3.D, Risk Factors
  158. [158] Item 3.D, Risk Factors
  159. [159] Item 3.D, Risk Factors
  160. [160] Item 3.D, Risk Factors
  161. [161] Item 3.D, Risk Factors
  162. [162] Item 3.D, Risk Factors
  163. [163] Item 3.D, Risk Factors
  164. [164] Item 3.D, Risk Factors
  165. [165] Item 3.D, Risk Factors
  166. [166] Item 3.D, Risk Factors
  167. [167] Item 3.D, Risk Factors
  168. [168] Item 3.D, Risk Factors
  169. [169] Item 3.D, Risk Factors
  170. [170] Item 3.D, Risk Factors
  171. [171] Item 3.D, Risk Factors
  172. [172] Item 3.D, Risk Factors
  173. [173] Item 3.D, Risk Factors
  174. [174] Item 3.D, Risk Factors
  175. [175] Item 3.D, Risk Factors
  176. [176] Item 3.D, Risk Factors
  177. [177] Item 3.D, Risk Factors
  178. [178] Item 3.D, Risk Factors
  179. [179] Item 3.D, Risk Factors
  180. [180] Item 3.D, Risk Factors
  181. [181] Item 3.D, Risk Factors
  182. [182] Item 3.D, Risk Factors
  183. [183] Item 3.D, Risk Factors
  184. [184] Item 3.D, Risk Factors
  185. [185] Item 3.D, Risk Factors
  186. [186] Item 3.D, Risk Factors
  187. [187] Item 3.D, Risk Factors
  188. [188] Item 3.D, Risk Factors
  189. [189] Item 3.D, Risk Factors
  190. [190] Item 3.D, Risk Factors
  191. [191] Item 3.D, Risk Factors
  192. [192] Item 3.D, Risk Factors
  193. [193] Item 3.D, Risk Factors
  194. [194] Item 3.D, Risk Factors
  195. [195] Item 3.D, Risk Factors
  196. [196] Item 3.D, Risk Factors
  197. [197] Item 3.D, Risk Factors
  198. [198] Item 3.D, Risk Factors
  199. [199] Item 3.D, Risk Factors
  200. [200] Item 3.D, Risk Factors
  201. [201] Item 3.D, Risk Factors
  202. [202] Item 3.D, Risk Factors
  203. [203] Item 3.D, Risk Factors
  204. [204] Item 3.D, Risk Factors
  205. [205] Item 3.D, Risk Factors
  206. [206] Item 3.D, Risk Factors
  207. [207] Item 3.D, Risk Factors
  208. [208] Item 3.D, Risk Factors
  209. [209] Item 3.D, Risk Factors
  210. [210] Item 3.D, Risk Factors
  211. [211] Item 3.D, Risk Factors
  212. [212] Item 3.D, Risk Factors
  213. [213] Item 3.D, Risk Factors
  214. [214] Item 3.D, Risk Factors
  215. [215] Item 3.D, Risk Factors
  216. [216] Item 3.D, Risk Factors
  217. [217] Item 3.D, Risk Factors
  218. [218] Item 3.D, Risk Factors
  219. [219] Item 3.D, Risk Factors
  220. [220] Item 3.D, Risk Factors
  221. [221] Item 3.D, Risk Factors
  222. [222] Item 3.D, Risk Factors
  223. [223] Item 3.D, Risk Factors
  224. [224] Item 3.D, Risk Factors
  225. [225] Item 3.D, Risk Factors
  226. [226] Item 3.D, Risk Factors
  227. [227] Item 3.D, Risk Factors
  228. [228] Item 3.D, Risk Factors
  229. [229] Item 3.D, Risk Factors
  230. [230] Item 3.D, Risk Factors
  231. [231] Item 3.D, Risk Factors
  232. [232] Item 3.D, Risk Factors
  233. [233] Item 3.D, Risk Factors
  234. [234] Item 3.D, Risk Factors
  235. [235] Item 3.D, Risk Factors
  236. [236] Item 3.D, Risk Factors
  237. [237] Item 3.D, Risk Factors
  238. [238] Item 3.D, Risk Factors
  239. [239] Item 3.D, Risk Factors
  240. [240] Item 3.D, Risk Factors
  241. [241] Item 3.D, Risk Factors
  242. [242] Item 3.D, Risk Factors
  243. [243] Item 3.D, Risk Factors
  244. [244] Item 3.D, Risk Factors
  245. [245] Item 3.D, Risk Factors
  246. [246] Item 3.D, Risk Factors
  247. [247] Item 3.D, Risk Factors
  248. [248] Item 3.D, Risk Factors
  249. [249] Item 3.D, Risk Factors
  250. [250] Item 3.D, Risk Factors
  251. [251] Item 3.D, Risk Factors
  252. [252] Item 3.D, Risk Factors
  253. [253] Item 3.D, Risk Factors
  254. [254] Item 3.D, Risk Factors
  255. [255] Item 3.D, Risk Factors
  256. [256] Item 3.D, Risk Factors
  257. [257] Item 3.D, Risk Factors
  258. [258] Item 3.D, Risk Factors
  259. [259] Item 3.D, Risk Factors
  260. [260] Item 3.D, Risk Factors
  261. [261] Item 3.D, Risk Factors
  262. [262] Item 3.D, Risk Factors
  263. [263] Item 3.D, Risk Factors
  264. [264] Item 3.D, Risk Factors
  265. [265] Item 3.D, Risk Factors
  266. [266] Item 3.D, Risk Factors
  267. [267] Item 3.D, Risk Factors
  268. [268] Item 3.D, Risk Factors
  269. [269] Item 3.D, Risk Factors
  270. [270] Item 3.D, Risk Factors
  271. [271] Item 3.D, Risk Factors
  272. [272] Item 3.D, Risk Factors
  273. [273] Item 3.D, Risk Factors
  274. [274] Item 3.D, Risk Factors
  275. [275] Item 3.D, Risk Factors
  276. [276] Item 3.D, Risk Factors
  277. [277] Item 3.D, Risk Factors
  278. [278] Item 3.D, Risk Factors
  279. [279] Item 3.D, Risk Factors
  280. [280] Item 3.D, Risk Factors
  281. [281] Item 3.D, Risk Factors
  282. [282] Item 3.D, Risk Factors
  283. [283] Item 3.D, Risk Factors
  284. [284] Item 3.D, Risk Factors
  285. [285] Item 3.D, Risk Factors
  286. [286] Item 3.D, Risk Factors
  287. [287] Item 3.D, Risk Factors
  288. [288] Item 3.D, Risk Factors
  289. [289] Item 3.D, Risk Factors
  290. [290] Item 3.D, Risk Factors
  291. [291] Item 3.D, Risk Factors
  292. [292] Item 3.D, Risk Factors
  293. [293] Item 3.D, Risk Factors
  294. [294] Item 3.D, Risk Factors
  295. [295] Item 3.D, Risk Factors
  296. [296] Item 3.D, Risk Factors
  297. [297] Item 3.D, Risk Factors
  298. [298] Item 3.D, Risk Factors
  299. [299] Item 3.D, Risk Factors
  300. [300] Item 3.D, Risk Factors
  301. [301] Item 3.D, Risk Factors
  302. [302] Item 3.D, Risk Factors
  303. [303] Item 3.D, Risk Factors
  304. [304] Item 3.D, Risk Factors
  305. [305] Item 3.D, Risk Factors
  306. [306] Item 3.D, Risk Factors
  307. [307] Item 3.D, Risk Factors
  308. [308] Item 3.D, Risk Factors
  309. [309] Item 3.D, Risk Factors
  310. [310] Item 3.D, Risk Factors
  311. [311] Item 3.D, Risk Factors
  312. [312] Item 3.D, Risk Factors
  313. [313] Item 3.D, Risk Factors
  314. [314] Item 3.D, Risk Factors
  315. [315] Item 3.D, Risk Factors
  316. [316] Item 3.D, Risk Factors
  317. [317] Item 3.D, Risk Factors
  318. [318] Item 3.D, Risk Factors
  319. [319] Item 3.D, Risk Factors
  320. [320] Item 3.D, Risk Factors
  321. [321] Item 3.D, Risk Factors
  322. [322] Item 3.D, Risk Factors
  323. [323] Item 3.D, Risk Factors
  324. [324] Item 3.D, Risk Factors
  325. [325] Item 3.D, Risk Factors
  326. [326] Item 3.D, Risk Factors
  327. [327] Item 3.D, Risk Factors
  328. [328] Item 3.D, Risk Factors
  329. [329] Item 3.D, Risk Factors
  330. [330] Item 3.D, Risk Factors
  331. [331] Item 3.D, Risk Factors
  332. [332] Item 3.D, Risk Factors
  333. [333] Item 3.D, Risk Factors
  334. [334] Item 3.D, Risk Factors
  335. [335] Item 3.D, Risk Factors
  336. [336] Item 3.D, Risk Factors
  337. [337] Item 3.D, Risk Factors
  338. [338] Item 3.D, Risk Factors
  339. [339] Item 3.D, Risk Factors
  340. [340] Item 3.D, Risk Factors
  341. [341] Item 3.D, Risk Factors
  342. [342] Item 3.D, Risk Factors
  343. [343] Item 3.D, Risk Factors
  344. [344] Item 3.D, Risk Factors
  345. [345] Item 3.D, Risk Factors
  346. [346] Item 3.D, Risk Factors
  347. [347] Item 3.D, Risk Factors
  348. [348] Item 3.D, Risk Factors
  349. [349] Item 3.D, Risk Factors
  350. [350] Item 3.D, Risk Factors
  351. [351] Item 3.D, Risk Factors
  352. [352] Item 3.D, Risk Factors
  353. [353] Item 3.D, Risk Factors
  354. [354] Item 3.D, Risk Factors
  355. [355] Item 3.D, Risk Factors
  356. [356] Item 3.D, Risk Factors
  357. [357] Item 3.D, Risk Factors
  358. [358] Item 3.D, Risk Factors
  359. [359] Item 3.D, Risk Factors
  360. [360] Item 3.D, Risk Factors
  361. [361] Item 3.D, Risk Factors
  362. [362] Item 3.D, Risk Factors
  363. [363] Item 3.D, Risk Factors
  364. [364] Item 3.D, Risk Factors
  365. [365] Item 3.D, Risk Factors
  366. [366] Item 3.D, Risk Factors
  367. [367] Item 3.D, Risk Factors
  368. [368] Item 3.D, Risk Factors
  369. [369] Item 3.D, Risk Factors
  370. [370] Item 3.D, Risk Factors
  371. [371] Item 3.D, Risk Factors
  372. [372] Item 3.D, Risk Factors
  373. [373] Item 3.D, Risk Factors
  374. [374] Item 3.D, Risk Factors
  375. [375] Item 3.D, Risk Factors
  376. [376] Item 3.D, Risk Factors
  377. [377] Item 3.D, Risk Factors
  378. [378] Item 3.D, Risk Factors
  379. [379] Item 3.D, Risk Factors
  380. [380] Item 3.D, Risk Factors
  381. [381] Item 3.D, Risk Factors
  382. [382] Item 3.D, Risk Factors
  383. [383] Item 3.D, Risk Factors
  384. [384] Item 3.D, Risk Factors
  385. [385] Item 3.D, Risk Factors
  386. [386] Item 3.D, Risk Factors
  387. [387] Item 3.D, Risk Factors
  388. [388] Item 3.D, Risk Factors
  389. [389] Item 3.D, Risk Factors
  390. [390] Item 3.D, Risk Factors
  391. [391] Item 3.D, Risk Factors
  392. [392] Item 3.D, Risk Factors
  393. [393] Item 3.D, Risk Factors
  394. [394] Item 3.D, Risk Factors
  395. [395] Item 3.D, Risk Factors
  396. [396] Item 3.D, Risk Factors
  397. [397] Item 3.D, Risk Factors
  398. [398] Item 3.D, Risk Factors
  399. [399] Item 3.D, Risk Factors
  400. [400] Item 3.D, Risk Factors
  401. [401] Item 3.D, Risk Factors
  402. [402] Item 3.D, Risk Factors
  403. [403] Item 3.D, Risk Factors
  404. [404] Item 3.D, Risk Factors
  405. [405] Item 3.D, Risk Factors
  406. [406] Item 3.D, Risk Factors
  407. [407] Item 3.D, Risk Factors
  408. [408] Item 3.D, Risk Factors
  409. [409] Item 3.D, Risk Factors
  410. [410] Item 3.D, Risk Factors
  411. [411] Item 3.D, Risk Factors
  412. [412] Item 3.D, Risk Factors
  413. [413] Item 3.D, Risk Factors
  414. [414] Item 3.D, Risk Factors
  415. [415] Item 3.D, Risk Factors
  416. [416] Item 3.D, Risk Factors
  417. [417] Item 3.D, Risk Factors
  418. [418] Item 3.D, Risk Factors
  419. [419] Item 3.D, Risk Factors
  420. [420] Item 3.D, Risk Factors
  421. [421] Item 3.D, Risk Factors
  422. [422] Item 3.D, Risk Factors
  423. [423] Item 3.D, Risk Factors
  424. [424] Item 3.D, Risk Factors
  425. [425] Item 3.D, Risk Factors
  426. [426] Item 3.D, Risk Factors
  427. [427] Item 3.D, Risk Factors
  428. [428] Item 3.D, Risk Factors
  429. [429] Item 3.D, Risk Factors
  430. [430] Item 3.D, Risk Factors
  431. [431] Item 3.D, Risk Factors
  432. [432] Item 3.D, Risk Factors
  433. [433] Item 3.D, Risk Factors
  434. [434] Item 3.D, Risk Factors
  435. [435] Item 3.D, Risk Factors
  436. [436] Item 3.D, Risk Factors
  437. [437] Item 3.D, Risk Factors
  438. [438] Item 3.D, Risk Factors
  439. [439] Item 3.D, Risk Factors
  440. [440] Item 3.D, Risk Factors
  441. [441] Item 3.D, Risk Factors
  442. [442] Item 3.D, Risk Factors
  443. [443] Item 3.D, Risk Factors
  444. [444] Item 3.D, Risk Factors
  445. [445] Item 3.D, Risk Factors
  446. [446] Item 3.D, Risk Factors
  447. [447] Item 3.D, Risk Factors
  448. [448] Item 3.D, Risk Factors
  449. [449] Item 3.D, Risk Factors
  450. [450] Item 3.D, Risk Factors
  451. [451] Item 3.D, Risk Factors
  452. [452] Item 3.D, Risk Factors
  453. [453] Item 3.D, Risk Factors
  454. [454] Item 3.D, Risk Factors
  455. [455] Item 3.D, Risk Factors
  456. [456] Item 3.D, Risk Factors
  457. [457] Item 3.D, Risk Factors
  458. [458] Item 3.D, Risk Factors
  459. [459] Item 3.D, Risk Factors
  460. [460] Item 3.D, Risk Factors
  461. [461] Item 3.D, Risk Factors
  462. [462] Item 3.D, Risk Factors
  463. [463] Item 3.D, Risk Factors
  464. [464] Item 3.D, Risk Factors
  465. [465] Item 3.D, Risk Factors
  466. [466] Item 3.D, Risk Factors
  467. [467] Item 3.D, Risk Factors
  468. [468] Item 3.D, Risk Factors
  469. [469] Item 3.D, Risk Factors
  470. [470] Item 3.D, Risk Factors
  471. [471] Item 3.D, Risk Factors
  472. [472] Item 3.D, Risk Factors
  473. [473] Item 3.D, Risk Factors
  474. [474] Item 3.D, Risk Factors
  475. [475] Item 3.D, Risk Factors
  476. [476] Item 3.D, Risk Factors
  477. [477] Item 3.D, Risk Factors
  478. [478] Item 3.D, Risk Factors
  479. [479] Item 3.D, Risk Factors
  480. [480] Item 3.D, Risk Factors
  481. [481] Item 3.D, Risk Factors
  482. [482] Item 3.D, Risk Factors
  483. [483] Item 3.D, Risk Factors
  484. [484] Item 3.D, Risk Factors
  485. [485] Item 3.D, Risk Factors
  486. [486] Item 3.D, Risk Factors
  487. [487] Item 3.D, Risk Factors
  488. [488] Item 3.D, Risk Factors
  489. [489] Item 3.D, Risk Factors
  490. [490] Item 3.D, Risk Factors
  491. [491] Item 3.D, Risk Factors
  492. [492] Item 3.D, Risk Factors
  493. [493] Item 3.D, Risk Factors
  494. [494] Item 3.D, Risk Factors
  495. [495] Item 3.D, Risk Factors
  496. [496] Item 3.D, Risk Factors
  497. [497] Item 3.D, Risk Factors
  498. [498] Item 3.D, Risk Factors
  499. [499] Item 3.D, Risk Factors
  500. [500] Item 3.D, Risk Factors
  501. [501] Item 3.D, Risk Factors
  502. [502] Item 3.D, Risk Factors
  503. [503] Item 3.D, Risk Factors
  504. [504] Item 3.D, Risk Factors
  505. [505] Item 3.D, Risk Factors
  506. [506] Item 3.D, Risk Factors
  507. [507] Item 3.D, Risk Factors
  508. [508] Item 3.D, Risk Factors
  509. [509] Item 3.D, Risk Factors
  510. [510] Item 3.D, Risk Factors
  511. [511] Item 3.D, Risk Factors
  512. [512] Item 3.D, Risk Factors
  513. [513] Item 3.D, Risk Factors
  514. [514] Item 3.D, Risk Factors
  515. [515] Item 3.D, Risk Factors
  516. [516] Item 3.D, Risk Factors
  517. [517] Item 3.D, Risk Factors
  518. [518] Item 3.D, Risk Factors
  519. [519] Item 3.D, Risk Factors
  520. [520] Item 3.D, Risk Factors
  521. [521] Item 3.D, Risk Factors
  522. [522] Item 3.D, Risk Factors
  523. [523] Item 3.D, Risk Factors
  524. [524] Item 3.D, Risk Factors
  525. [525] Item 3.D, Risk Factors
  526. [526] Item 3.D, Risk Factors
  527. [527] Item 3.D, Risk Factors
  528. [528] Item 3.D, Risk Factors
  529. [529] Item 3.D, Risk Factors
  530. [530] Item 3.D, Risk Factors
  531. [531] Item 3.D, Risk Factors
  532. [532] Item 3.D, Risk Factors
  533. [533] Item 3.D, Risk Factors
  534. [534] Item 3.D, Risk Factors
  535. [535] Item 3.D, Risk Factors
  536. [536] Item 3.D, Risk Factors
  537. [537] Item 3.D, Risk Factors
  538. [538] Item 3.D, Risk Factors
  539. [539] Item 3.D, Risk Factors
  540. [540] Item 3.D, Risk Factors
  541. [541] Item 3.D, Risk Factors
  542. [542] Item 3.D, Risk Factors
  543. [543] Item 3.D, Risk Factors
  544. [544] Item 3.D, Risk Factors
  545. [545] Item 3.D, Risk Factors
  546. [546] Item 3.D, Risk Factors
  547. [547] Item 3.D, Risk Factors
  548. [548] Item 3.D, Risk Factors
  549. [549] Item 3.D, Risk Factors
  550. [550] Item 3.D, Risk Factors
  551. [551] Item 3.D, Risk Factors
  552. [552] Item 3.D, Risk Factors
  553. [553] Item 3.D, Risk Factors
  554. [554] Item 3.D, Risk Factors
  555. [555] Item 3.D, Risk Factors
  556. [556] Item 3.D, Risk Factors
  557. [557] Item 3.D, Risk Factors
  558. [558] Item 3.D, Risk Factors
  559. [559] Item 3.D, Risk Factors
  560. [560] Item 3.D, Risk Factors
  561. [561] Item 3.D, Risk Factors
  562. [562] Item 3.D, Risk Factors
  563. [563] Item 3.D, Risk Factors
  564. [564] Item 3.D, Risk Factors
  565. [565] Item 3.D, Risk Factors
  566. [566] Item 3.D, Risk Factors
  567. [567] Item 3.D, Risk Factors
  568. [568] Item 3.D, Risk Factors
  569. [569] Item 3.D, Risk Factors
  570. [570] Item 3.D, Risk Factors
  571. [571] Item 3.D, Risk Factors
  572. [572] Item 3.D, Risk Factors
  573. [573] Item 3.D, Risk Factors
  574. [574] Item 3.D, Risk Factors
  575. [575] Item 3.D, Risk Factors
  576. [576] Item 3.D, Risk Factors
  577. [577] Item 3.D, Risk Factors
  578. [578] Item 3.D, Risk Factors
  579. [579] Item 3.D, Risk Factors
  580. [580] Item 3.D, Risk Factors
  581. [581] Item 3.D, Risk Factors
  582. [582] Item 3.D, Risk Factors
  583. [583] Item 3.D, Risk Factors
  584. [584] Item 3.D, Risk Factors
  585. [585] Item 3.D, Risk Factors
  586. [586] Item 3.D, Risk Factors
  587. [587] Item 3.D, Risk Factors
  588. [588] Item 3.D, Risk Factors
  589. [589] Item 3.D, Risk Factors
  590. [590] Item 3.D, Risk Factors
  591. [591] Item 3.D, Risk Factors
  592. [592] Item 3.D, Risk Factors
  593. [593] Item 3.D, Risk Factors
  594. [594] Item 3.D, Risk Factors
  595. [595] Item 3.D, Risk Factors
  596. [596] Item 3.D, Risk Factors
  597. [597] Item 3.D, Risk Factors
  598. [598] Item 3.D, Risk Factors
  599. [599] Item 3.D, Risk Factors
  600. [600] Item 3.D, Risk Factors
  601. [601] Item 3.D, Risk Factors
  602. [602] Item 3.D, Risk Factors
  603. [603] Item 3.D, Risk Factors
  604. [604] Item 3.D, Risk Factors
  605. [605] Item 3.D, Risk Factors
  606. [606] Item 3.D, Risk Factors
  607. [607] Item 3.D, Risk Factors
  608. [608] Item 3.D, Risk Factors
  609. [609] Item 3.D, Risk Factors
  610. [610] Item 3.D, Risk Factors
  611. [611] Item 3.D, Risk Factors
  612. [612] Item 3.D, Risk Factors
  613. [613] Item 3.D, Risk Factors
  614. [614] Item 3.D, Risk Factors
  615. [615] Item 3.D, Risk Factors
  616. [616] Item 3.D, Risk Factors
  617. [617] Item 3.D, Risk Factors
  618. [618] Item 3.D, Risk Factors
  619. [619] Item 3.D, Risk Factors
  620. [620] Item 3.D, Risk Factors
  621. [621] Item 3.D, Risk Factors
  622. [622] Item 3.D, Risk Factors
  623. [623] Item 3.D, Risk Factors
  624. [624] Item 3.D, Risk Factors
  625. [625] Item 3.D, Risk Factors
  626. [626] Item 3.D, Risk Factors
  627. [627] Item 3.D, Risk Factors
  628. [628] Item 3.D, Risk Factors
  629. [629] Item 3.D, Risk Factors
  630. [630] Item 3.D, Risk Factors
  631. [631] Item 3.D, Risk Factors
  632. [632] Item 3.D, Risk Factors
  633. [633] Item 3.D, Risk Factors
  634. [634] Item 3.D, Risk Factors
  635. [635] Item 3.D, Risk Factors
  636. [636] Item 3.D, Risk Factors
  637. [637] Item 3.D, Risk Factors
  638. [638] Item 3.D, Risk Factors
  639. [639] Item 3.D, Risk Factors
  640. [640] Item 3.D, Risk Factors
  641. [641] Item 3.D, Risk Factors
  642. [642] Item 3.D, Risk Factors
  643. [643] Item 3.D, Risk Factors
  644. [644] Item 3.D, Risk Factors
  645. [645] Item 3.D, Risk Factors
  646. [646] Item 3.D, Risk Factors
  647. [647] Item 3.D, Risk Factors
  648. [648] Item 3.D, Risk Factors
  649. [649] Item 3.D, Risk Factors
  650. [650] Item 3.D, Risk Factors
  651. [651] Item 3.D, Risk Factors
  652. [652] Item 3.D, Risk Factors
  653. [653] Item 3.D, Risk Factors
  654. [654] Item 3.D, Risk Factors
  655. [655] Item 3.D, Risk Factors
  656. [656] Item 3.D, Risk Factors
  657. [657] Item 3.D, Risk Factors
  658. [658] Item 3.D, Risk Factors
  659. [659] Item 3.D, Risk Factors
  660. [660] Item 3.D, Risk Factors
  661. [661] Item 3.D, Risk Factors
  662. [662] Item 3.D, Risk Factors
  663. [663] Item 3.D, Risk Factors
  664. [664] Item 3.D, Risk Factors
  665. [665] Item 3.D, Risk Factors
  666. [666] Item 3.D, Risk Factors
  667. [667] Item 3.D, Risk Factors
  668. [668] Item 3.D, Risk Factors
  669. [669] Item 3.D, Risk Factors
  670. [670] Item 3.D, Risk Factors
  671. [671] Item 3.D, Risk Factors
  672. [672] Item 3.D, Risk Factors
  673. [673] Item 3.D, Risk Factors
  674. [674] Item 3.D, Risk Factors
  675. [675] Item 3.D, Risk Factors
  676. [676] Item 3.D, Risk Factors
  677. [677] Item 3.D, Risk Factors
  678. [678] Item 3.D, Risk Factors
  679. [679] Item 3.D, Risk Factors
  680. [680] Item 3.D, Risk Factors
  681. [681] Item 3.D, Risk Factors
  682. [682] Item 3.D, Risk Factors
  683. [683] Item 3.D, Risk Factors
  684. [684] Item 3.D, Risk Factors
  685. [685] Item 3.D, Risk Factors
  686. [686] Item 3.D, Risk Factors
  687. [687] Item 3.D, Risk Factors
  688. [688] Item 3.D, Risk Factors
  689. [689] Item 3.D, Risk Factors
  690. [690] Item 3.D, Risk Factors
  691. [691] Item 3.D, Risk Factors
  692. [692] Item 3.D, Risk Factors
  693. [693] Item 3.D, Risk Factors
  694. [694] Item 3.D, Risk Factors
  695. [695] Item 3.D, Risk Factors
  696. [696] Item 3.D, Risk Factors
  697. [697] Item 3.D, Risk Factors
  698. [698] Item 3.D, Risk Factors
  699. [699] Item 3.D, Risk Factors
  700. [700] Item 3.D, Risk Factors
  701. [701] Item 3.D, Risk Factors
  702. [702] Item 3.D, Risk Factors
  703. [703] Item 3.D, Risk Factors
  704. [704] Item 3.D, Risk Factors
  705. [705] Item 3.D, Risk Factors
  706. [706] Item 3.D, Risk Factors
  707. [707] Item 3.D, Risk Factors
  708. [708] Item 3.D, Risk Factors
  709. [709] Item 3.D, Risk Factors
  710. [710] Item 3.D, Risk Factors
  711. [711] Item 3.D, Risk Factors
  712. [712] Item 3.D, Risk Factors
  713. [713] Item 3.D, Risk Factors
  714. [714] Item 3.D, Risk Factors
  715. [715] Item 3.D, Risk Factors
  716. [716] Item 3.D, Risk Factors
  717. [717] Item 3.D, Risk Factors
  718. [718] Item 3.D, Risk Factors
  719. [719] Item 3.D, Risk Factors
  720. [720] Item 3.D, Risk Factors
  721. [721] Item 3.D, Risk Factors
  722. [722] Item 3.D, Risk Factors
  723. [723] Item 3.D, Risk Factors
  724. [724] Item 3.D, Risk Factors
  725. [725] Item 3.D, Risk Factors
  726. [726] Item 3.D, Risk Factors
  727. [727] Item 3.D, Risk Factors
  728. [728] Item 3.D, Risk Factors
  729. [729] Item 3.D, Risk Factors
  730. [730] Item 3.D, Risk Factors
  731. [731] Item 3.D, Risk Factors
  732. [732] Item 3.D, Risk Factors
  733. [733] Item 3.D, Risk Factors
  734. [734] Item 3.D, Risk Factors
  735. [735] Item 3.D, Risk Factors
  736. [736] Item 3.D, Risk Factors
  737. [737] Item 3.D, Risk Factors
  738. [738] Item 3.D, Risk Factors
  739. [739] Item 3.D, Risk Factors
  740. [740] Item 3.D, Risk Factors
  741. [741] Item 3.D, Risk Factors
  742. [742] Item 3.D, Risk Factors
  743. [743] Item 3.D, Risk Factors
  744. [744] Item 3.D, Risk Factors
  745. [745] Item 3.D, Risk Factors
  746. [746] Item 3.D, Risk Factors
  747. [747] Item 3.D, Risk Factors
  748. [748] Item 3.D, Risk Factors
  749. [749] Item 3.D, Risk Factors
  750. [750] Item 3.D, Risk Factors
  751. [751] Item 3.D, Risk Factors
  752. [752] Item 3.D, Risk Factors
  753. [753] Item 3.D, Risk Factors
  754. [754] Item 3.D, Risk Factors
  755. [755] Item 3.D, Risk Factors
  756. [756] Item 3.D, Risk Factors
  757. [757] Item 3.D, Risk Factors
  758. [758] Item 3.D, Risk Factors
  759. [759] Item 3.D, Risk Factors
  760. [760] Item 3.D, Risk Factors
  761. [761] Item 3.D, Risk Factors
  762. [762] Item 3.D, Risk Factors
  763. [763] Item 3.D, Risk Factors
  764. [764] Item 3.D, Risk Factors
  765. [765] Item 3.D, Risk Factors
  766. [766] Item 3.D, Risk Factors
  767. [767] Item 3.D, Risk Factors
  768. [768] Item 3.D, Risk Factors
  769. [769] Item 3.D, Risk Factors
  770. [770] Item 3.D, Risk Factors
  771. [771] Item 3.D, Risk Factors
  772. [772] Item 3.D, Risk Factors
  773. [773] Item 3.D, Risk Factors
  774. [774] Item 3.D, Risk Factors
  775. [775] Item 3.D, Risk Factors
  776. [776] Item 3.D, Risk Factors
  777. [777] Item 3.D, Risk Factors
  778. [778] Item 3.D, Risk Factors
  779. [779] Item 3.D, Risk Factors
  780. [780] Item 3.D, Risk Factors
  781. [781] Item 3.D, Risk Factors
  782. [782] Item 3.D, Risk Factors
  783. [783] Item 3.D, Risk Factors
  784. [784] Item 3.D, Risk Factors
  785. [785] Item 3.D, Risk Factors
  786. [786] Item 3.D, Risk Factors
  787. [787] Item 3.D, Risk Factors
  788. [788] Item 3.D, Risk Factors
  789. [789] Item 3.D, Risk Factors
  790. [790] Item 3.D, Risk Factors
  791. [791] Item 3.D, Risk Factors
  792. [792] Item 3.D, Risk Factors
  793. [793] Item 3.D, Risk Factors
  794. [794] Item 3.D, Risk Factors
  795. [795] Item 3.D, Risk Factors
  796. [796] Item 3.D, Risk Factors
  797. [797] Item 3.D, Risk Factors
  798. [798] Item 3.D, Risk Factors
  799. [799] Item 3.D, Risk Factors
  800. [800] Item 3.D, Risk Factors
  801. [801] Item 3.D, Risk Factors
  802. [802] Item 3.D, Risk Factors
  803. [803] Item 3.D, Risk Factors
  804. [804] Item 3.D, Risk Factors
  805. [805] Item 3.D, Risk Factors
  806. [806] Item 3.D, Risk Factors
  807. [807] Item 3.D, Risk Factors
  808. [808] Item 3.D, Risk Factors
  809. [809] Item 3.D, Risk Factors
  810. [810] Item 3.D, Risk Factors
  811. [811] Item 3.D, Risk Factors
  812. [812] Item 3.D, Risk Factors
  813. [813] Item 3.D, Risk Factors
  814. [814] Item 3.D, Risk Factors
  815. [815] Item 3.D, Risk Factors
  816. [816] Item 3.D, Risk Factors
  817. [817] Item 3.D, Risk Factors
  818. [818] Item 3.D, Risk Factors
  819. [819] Item 3.D, Risk Factors
  820. [820] Item 3.D, Risk Factors
  821. [821] Item 3.D, Risk Factors
  822. [822] Item 3.D, Risk Factors
  823. [823] Item 3.D, Risk Factors
  824. [824] Item 3.D, Risk Factors
  825. [825] Item 3.D, Risk Factors
  826. [826] Item 3.D, Risk Factors
  827. [827] Item 3.D, Risk Factors
  828. [828] Item 3.D, Risk Factors
  829. [829] Item 3.D, Risk Factors
  830. [830] Item 3.D, Risk Factors
  831. [831] Item 3.D, Risk Factors
  832. [832] Item 3.D, Risk Factors
  833. [833] Item 3.D, Risk Factors
  834. [834] Item 3.D, Risk Factors
  835. [835] Item 3.D, Risk Factors
  836. [836] Item 3.D, Risk Factors
  837. [837] Item 3.D, Risk Factors
  838. [838] Item 3.D, Risk Factors
  839. [839] Item 3.D, Risk Factors
  840. [840] Item 3.D, Risk Factors
  841. [841] Item 3.D, Risk Factors
  842. [842] Item 3.D, Risk Factors
  843. [843] Item 3.D, Risk Factors
  844. [844] Item 3.D, Risk Factors
  845. [845] Item 3.D, Risk Factors
  846. [846] Item 3.D, Risk Factors
  847. [847] Item 3.D, Risk Factors
  848. [848] Item 3.D, Risk Factors
  849. [849] Item 3.D, Risk Factors
  850. [850] Item 3.D, Risk Factors
  851. [851] Item 3.D, Risk Factors
  852. [852] Item 3.D, Risk Factors
  853. [853] Item 3.D, Risk Factors
  854. [854] Item 3.D, Risk Factors
  855. [855] Item 3.D, Risk Factors
  856. [856] Item 3.D, Risk Factors
  857. [857] Item 3.D, Risk Factors
  858. [858] Item 3.D, Risk Factors
  859. [859] Item 3.D, Risk Factors
  860. [860] Item 3.D, Risk Factors
  861. [861] Item 3.D, Risk Factors
  862. [862] Item 3.D, Risk Factors
  863. [863] Item 3.D, Risk Factors
  864. [864] Item 3.D, Risk Factors
  865. [865] Item 3.D, Risk Factors
  866. [866] Item 3.D, Risk Factors
  867. [867] Item 3.D, Risk Factors
  868. [868] Item 3.D, Risk Factors
  869. [869] Item 3.D, Risk Factors
  870. [870] Item 3.D, Risk Factors
  871. [871] Item 3.D, Risk Factors
  872. [872] Item 3.D, Risk Factors
  873. [873] Item 3.D, Risk Factors
  874. [874] Item 3.D, Risk Factors
  875. [875] Item 3.D, Risk Factors
  876. [876] Item 3.D, Risk Factors
  877. [877] Item 3.D, Risk Factors
  878. [878] Item 3.D, Risk Factors
  879. [879] Item 3.D, Risk Factors
  880. [880] Item 3.D, Risk Factors
  881. [881] Item 3.D, Risk Factors
  882. [882] Item 3.D, Risk Factors
  883. [883] Item 3.D, Risk Factors
  884. [884] Item 3.D, Risk Factors
  885. [885] Item 3.D, Risk Factors
  886. [886] Item 3.D, Risk Factors
  887. [887] Item 3.D, Risk Factors
  888. [888] Item 3.D, Risk Factors
  889. [889] Item 3.D, Risk Factors
  890. [890] Item 3.D, Risk Factors
  891. [891] Item 3.D, Risk Factors
  892. [892] Item 3.D, Risk Factors
  893. [893] Item 3.D, Risk Factors
  894. [894] Item 3.D, Risk Factors
  895. [895] Item 3.D, Risk Factors
  896. [896] Item 3.D, Risk Factors
  897. [897] Item 3.D, Risk Factors
  898. [898] Item 3.D, Risk Factors
  899. [899] Item 3.D, Risk Factors
  900. [900] Item 3.D, Risk Factors
  901. [901] Item 3.D, Risk Factors
  902. [902] Item 3.D, Risk Factors
  903. [903] Item 3.D, Risk Factors
  904. [904] Item 3.D, Risk Factors
  905. [905] Item 3.D, Risk Factors
  906. [906] Item 3.D, Risk Factors
  907. [907] Item 3.D, Risk Factors
  908. [908] Item 3.D, Risk Factors
  909. [909] Item 3.D, Risk Factors
  910. [910] Item 3.D, Risk Factors
  911. [911] Item 3.D, Risk Factors
  912. [912] Item 3.D, Risk Factors
  913. [913] Item 3.D, Risk Factors
  914. [914] Item 3.D, Risk Factors
  915. [915] Item 3.D, Risk Factors
  916. [916] Item 3.D, Risk Factors
  917. [917] Item 3.D, Risk Factors
  918. [918] Item 3.D, Risk Factors
  919. [919] Item 3.D, Risk Factors
  920. [920] Item 3.D, Risk Factors
  921. [921] Item 3.D, Risk Factors
  922. [922] Item 3.D, Risk Factors
  923. [923] Item 3.D, Risk Factors
  924. [924] Item 3.D, Risk Factors
  925. [925] Item 3.D, Risk Factors
  926. [926] Item 3.D, Risk Factors
  927. [927] Item 3.D, Risk Factors
  928. [928] Item 3.D, Risk Factors
  929. [929] Item 3.D, Risk Factors
  930. [930] Item 3.D, Risk Factors
  931. [931] Item 3.D, Risk Factors
  932. [932] Item 3.D, Risk Factors
  933. [933] Item 3.D, Risk Factors
  934. [934] Item 3.D, Risk Factors
  935. [935] Item 3.D, Risk Factors
  936. [936] Item 3.D, Risk Factors
  937. [937] Item 3.D, Risk Factors
  938. [938] Item 3.D, Risk Factors
  939. [939] Item 3.D, Risk Factors
  940. [940] Item 3.D, Risk Factors
  941. [941] Item 3.D, Risk Factors
  942. [942] Item 3.D, Risk Factors
  943. [943] Item 3.D, Risk Factors
  944. [944] Item 3.D, Risk Factors
  945. [945] Item 3.D, Risk Factors
  946. [946] Item 3.D, Risk Factors
  947. [947] Item 3.D, Risk Factors
  948. [948] Item 3.D, Risk Factors
  949. [949] Item 3.D, Risk Factors
  950. [950] Item 3.D, Risk Factors
  951. [951] Item 3.D, Risk Factors
  952. [952] Item 3.D, Risk Factors
  953. [953] Item 3.D, Risk Factors
  954. [954] Item 3.D, Risk Factors
  955. [955] Item 3.D, Risk Factors
  956. [956] Item 3.D, Risk Factors
  957. [957] Item 3.D, Risk Factors
  958. [958] Item 3.D, Risk Factors
  959. [959] Item 3.D, Risk Factors
  960. [960] Item 3.D, Risk Factors
  961. [961] Item 3.D, Risk Factors
  962. [962] Item 3.D, Risk Factors
  963. [963] Item 3.D, Risk Factors
  964. [964] Item 3.D, Risk Factors
  965. [965] Item 3.D, Risk Factors
  966. [966] Item 3.D, Risk Factors
  967. [967] Item 3.D, Risk Factors
  968. [968] Item 3.D, Risk Factors
  969. [969] Item 3.D, Risk Factors
  970. [970] Item 3.D, Risk Factors
  971. [971] Item 3.D, Risk Factors
  972. [972] Item 3.D, Risk Factors
  973. [973] Item 3.D, Risk Factors
  974. [974] Item 3.D, Risk Factors
  975. [975] Item 3.D, Risk Factors
  976. [976] Item 3.D, Risk Factors
  977. [977] Item 3.D, Risk Factors
  978. [978] Item 3.D, Risk Factors
  979. [979] Item 3.D, Risk Factors
  980. [980] Item 3.D, Risk Factors
  981. [981] Item 3.D, Risk Factors
  982. [982] Item 3.D, Risk Factors
  983. [983] Item 3.D, Risk Factors
  984. [984] Item 3.D, Risk Factors
  985. [985] Item 3.D, Risk Factors
  986. [986] Item 3.D, Risk Factors
  987. [987] Item 3.D, Risk Factors
  988. [988] Item 3.D, Risk Factors
  989. [989] Item 3.D, Risk Factors
  990. [990] Item 3.D, Risk Factors
  991. [991] Item 3.D, Risk Factors
  992. [992] Item 3.D, Risk Factors
  993. [993] Item 3.D, Risk Factors
  994. [994] Item 3.D, Risk Factors
  995. [995] Item 3.D, Risk Factors
  996. [996] Item 3.D, Risk Factors
  997. [997] Item 3.D, Risk Factors
  998. [998] Item 3.D, Risk Factors
  999. [999] Item 3.D, Risk Factors
  1000. [1000] Item 3.D, Risk Factors

Analysis on 9/30/2026